Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model

Journal of Surgical Research

Volumn 95, Issue 2, 2001, Pages 167-173

  Sunose, Yutaka ^a   Takeyoshi, Izumi ^a   Tsutsumi, Hirofumi ^a   Kawata, Kiyoshi ^a   Tokumine, Masahiko ^a   Iwazaki, Shigeru ^a   Tomizawa, Naoki ^a   Ohwada, Susumu ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

6 ketoPGF1 ; FK3311; Ischemia reperfusion injury; Lung; TxB2

Indexed keywords

4' ACETYL 2' (2,4 DIFLUOROPHENOXY)METHANESULFONANILIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 2 INHIBITOR; THROMBOXANE B2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART OUTPUT; HISTOPATHOLOGY; ISCHEMIA; LEUKOCYTE COUNT; LUNG EDEMA; LUNG VASCULAR RESISTANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PULMONARY ARTERY; REPERFUSION INJURY; SURVIVAL RATE;

EID: 0035746991     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.6018     Document Type: Article

References (37)

1. Lung transplantation
2. Lung preservation: A review of current practice and future directions
3. Worldwide thoracic organ transplantation: A report from the UNOS/ISHLT International Registry for thoracic organ transplantation
4. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
5. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement
6. An update on the current status of lung transplantation: Report of the St. Louis International Lung Transplant Registry
7. Lung transplantation comes of age
8. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate
9. Endotoxin-induced lung injury in rats: Role of eicosanoids
10. Role and regulation of cyclooxygenase-2 during inflammation
11. Studies on antiinflammatory agents. III. Synthesis and pharmacological properties of metabolites of 4′-acetyl-2′-(2,4-difluorophenoxy) methanesulfonanilide (FK3311)
12. Low-dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function
13. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in canine lung transplantation model
14. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors
15. 2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages
16. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury
17. Effects of arachidonate on permeability and resistance distribution in canine lungs
18. Cyclooxygenase-1 and cyclo-oxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
19. Human platelet/erythroleukemia cell prosta-glandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment
20. Pulmonary thromboxane release following intestinal reperfusion
21. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation
22. Prevention of ischemia reperfusion lung injury by inhaled nitric oxide in neonatal piglets
23. cAMP-mediated vascular protection in an orthotopic rat lung transplant model
24. 2 analogue and prostacyclin on lung fluid balance in newborn lambs
25. Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs
26. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation
27. Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation
28. Edema from cyclooxygenase products of endogenous arachidonic acid in isolated lung
29. 2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice
30. Extended ex vivo preservation of the heart and lungs. Effects of a cellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation
31. 2 moderate postischemic renal failure
32. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited
33. 2 synthetase inhibitor against ischemic liver injury
34. 2 as a biochemical parameter for evaluating lung damage during preservation
35. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation
36. 2 moderates permeability after limbischemia
37. 2 and superoxide dismutase on reperfusion injury of warm ischemic lung